Briska Jifrina Premnath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Briska Jifrina Premnath has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Manoj Kumar Srinivasan
Department of ENT, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, India
3 shared publications - Namasivayam Nalini
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar 608 002, Tamilnadu, India
2 shared publications - Chandramohan Govindasamy
Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Saudi Arabia
1 shared publication Nalini Namasivayam
Department of Biochemistry and Biotechnology Faculty of Science, Annamalai University Chidambaram Tamil Nadu India
1 shared publicationRamya Parimelazhagan
Department of Biochemistry, Faculty of Medicine, Sri Lakshmi Narayana Institute of Medical Sciences (SLIMS), Puducherry, India
1 shared publication- Seralathan Kamala-Kannan
Division of Biotechnology, Advanced Institute of Environment and Bioscience, College of Environmental and Bioresource Sciences, Jeonbuk National University, Iksan, Republic of Korea
1 shared publication
Latest Publications
- 2 May 2025
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (5) , e70262
Evaluation of Carvacrol Zinc Oxide Quantum Dots in Mitigating Hepatic Inflammation and Function Impairment in DMBA‐Induced Mammary Carcinogenesis
The liver plays a crucial role in metabolizing and purging various substances from the body. Exposure to toxins like DMBA (7,12‐dimethylbenz[a]anthracene) can harm the liver, leading to inflammation, impaired function, and the potential development of liver lesions or tumors. The present study explored the protective effect of CVC‐ZnO QDs (carvacrol‐zinc oxide quantum dots) on the liver by DMBA‐induced mammary carcinoma. Female Sprague Dawley rats were used, and mammary cancer was initiated by injecting DMBA near the mammary gland. Different concentrations of CVC‐ZnO QDs were administered orally to determine the most effective dosage. Various liver tissue factors were evaluated, including liver marker enzymes, antioxidant status, lipid peroxidation, detoxification enzyme activities and protein bound carbohydrates. Additionally, the inflammatory response of the liver tissue was investigated using immunohistochemistry and PCR. Results revealed that rats treated with CVC‐ZnO QDs showed a significant decrease in liver marker enzymes, lipid peroxidation levels, Phase I detoxification enzyme activities and protein bound carbohydrates. CVC‐ZnO QDs also increased Phase II detoxification enzyme activity, and antioxidant levels compared to rats treated solely with DMBA. Histopathological analysis confirmed that CVC‐ZnO QDs shielded the liver from DMBA‐induced damage. Furthermore, CVC‐ZnO QDs were found to reduce the expression of IL‐6, NF‐κB, and COX‐2 in DMBA‐induced rats. Overall, the study demonstrated that administering CVC‐ZnO QDs at a dose of 4 mg/kg b.w had a notable hepatoprotective effect against DMBA‐induced mammary cancer in rats.
- 2 May 2025
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (5) , e70262
Evaluation of Carvacrol Zinc Oxide Quantum Dots in Mitigating Hepatic Inflammation and Function Impairment in DMBA‐Induced Mammary Carcinogenesis
The liver plays a crucial role in metabolizing and purging various substances from the body. Exposure to toxins like DMBA (7,12‐dimethylbenz[a]anthracene) can harm the liver, leading to inflammation, impaired function, and the potential development of liver lesions or tumors. The present study explored the protective effect of CVC‐ZnO QDs (carvacrol‐zinc oxide quantum dots) on the liver by DMBA‐induced mammary carcinoma. Female Sprague Dawley rats were used, and mammary cancer was initiated by injecting DMBA near the mammary gland. Different concentrations of CVC‐ZnO QDs were administered orally to determine the most effective dosage. Various liver tissue factors were evaluated, including liver marker enzymes, antioxidant status, lipid peroxidation, detoxification enzyme activities and protein bound carbohydrates. Additionally, the inflammatory response of the liver tissue was investigated using immunohistochemistry and PCR. Results revealed that rats treated with CVC‐ZnO QDs showed a significant decrease in liver marker enzymes, lipid peroxidation levels, Phase I detoxification enzyme activities and protein bound carbohydrates. CVC‐ZnO QDs also increased Phase II detoxification enzyme activity, and antioxidant levels compared to rats treated solely with DMBA. Histopathological analysis confirmed that CVC‐ZnO QDs shielded the liver from DMBA‐induced damage. Furthermore, CVC‐ZnO QDs were found to reduce the expression of IL‐6, NF‐κB, and COX‐2 in DMBA‐induced rats. Overall, the study demonstrated that administering CVC‐ZnO QDs at a dose of 4 mg/kg b.w had a notable hepatoprotective effect against DMBA‐induced mammary cancer in rats.
- Open Access
- 30 March 2024
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 21 (1) , 211-228
Effect of Rutin on the Behavioural, Biochemical and Liver Morphological Changes in Danio Rerio Exposed to Reduced Graphene Oxide (Rgo) Nanoparticles
Biosciences, Biotechnology Research Asia is an international, open access, peer reviewed research journal covering all aspects of Biosciences and Biotechnology field.
- 30 March 2024
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 21 (1) , 211-228
Open AccessEffect of Rutin on the Behavioural, Biochemical and Liver Morphological Changes in Danio Rerio Exposed to Reduced Graphene Oxide (Rgo) Nanoparticles
Biosciences, Biotechnology Research Asia is an international, open access, peer reviewed research journal covering all aspects of Biosciences and Biotechnology field.
- Open Access
- 1 February 2024
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 36 (2) , 103029
Anticancer effects of pH- sensitive carvacrol zinc oxide quantum dots on DMBA induced mammary carcinoma in female sprague dawley rats
Objectives: The current research explores the anticancer effects of pH sensitive CVC-ZnO QDs (Carvacrol-loaded Zinc Oxide Quantum Dots) on DMBA induced mammary carcinoma in rats. Methods: Female SD rats were used, and mammary cancer was induced by chemical carcinogen via subcutaneous injection near the mammary gland. Different concentrations of CVC-ZnO QDs were orally supplemented to evaluate the optimum dose. We assessed the growth rate, body weight changes, tumor volume, tumor incidence and tumor burden in both the inducer and treatment groups. We also evaluated the biochemical parameters (antioxidant status, lipid peroxidation, detoxification enzymes, and lipid profile) and histopathological changes in the kidney and mammary tissues. Results: Our findings indicate that CVC-ZnO QDs treated rats significantly decreased the tumor weight, incidence, burden, lipid peroxidation levels, phase I detoxification enzyme activities and increased the body weight, phase II detoxification enzyme activities, and antioxidant status compared to the DMBA alone treated rats. CVC-ZnO QDs treatment also altered the lipid profile of plasma and mammary tissue. Furthermore, histopathological results confirmed that the CVC-ZnO QDs protect against DMBA-mediated damage to the mammary and kidney. Conclusion: The findings indicate that the CVC-ZnO QDs administered at 4 mg/kg b.w exhibited a significant anticancer effect against DMBA-induced mammary cancer.
- 1 February 2024
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 36 (2) , 103029
Open AccessAnticancer effects of pH- sensitive carvacrol zinc oxide quantum dots on DMBA induced mammary carcinoma in female sprague dawley rats
Objectives: The current research explores the anticancer effects of pH sensitive CVC-ZnO QDs (Carvacrol-loaded Zinc Oxide Quantum Dots) on DMBA induced mammary carcinoma in rats. Methods: Female SD rats were used, and mammary cancer was induced by chemical carcinogen via subcutaneous injection near the mammary gland. Different concentrations of CVC-ZnO QDs were orally supplemented to evaluate the optimum dose. We assessed the growth rate, body weight changes, tumor volume, tumor incidence and tumor burden in both the inducer and treatment groups. We also evaluated the biochemical parameters (antioxidant status, lipid peroxidation, detoxification enzymes, and lipid profile) and histopathological changes in the kidney and mammary tissues. Results: Our findings indicate that CVC-ZnO QDs treated rats significantly decreased the tumor weight, incidence, burden, lipid peroxidation levels, phase I detoxification enzyme activities and increased the body weight, phase II detoxification enzyme activities, and antioxidant status compared to the DMBA alone treated rats. CVC-ZnO QDs treatment also altered the lipid profile of plasma and mammary tissue. Furthermore, histopathological results confirmed that the CVC-ZnO QDs protect against DMBA-mediated damage to the mammary and kidney. Conclusion: The findings indicate that the CVC-ZnO QDs administered at 4 mg/kg b.w exhibited a significant anticancer effect against DMBA-induced mammary cancer.